Error in Introduction
The Original Investigation titled “Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance,” published online May 4, 2023, was corrected to fix an error in the expenditure listed in the second sentence of the article in the Introduction; $139 billion was revised to $134 billion. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - June 1, 2023 Category: Opthalmology Source Type: research
JAMA Ophthalmology Peer Reviewers in 2022
We sincerely thank the 427 peer reviewers who completed manuscript reviews for JAMA Ophthalmology in 2022. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 18, 2023 Category: Opthalmology Source Type: research
Double Optic Disc Pit With Retinal Pigmentation in a Woman With High Myopia
This case report discusses a diagnosis of 2 optic disc pits in an otherwise asymptomatic woman with high myopia. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 18, 2023 Category: Opthalmology Source Type: research
Subconjunctival Thelazia in a Chinese Woman Aged 49 Years
This case report describes a diagnosis of subconjunctival Thelazia callipaeda in a 49-year-old Chinese woman who presented with pruritis and a crawling sensation of the left eye for 1 week. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 18, 2023 Category: Opthalmology Source Type: research
Intravitreal Glioma in a Boy Aged 7 Years
This case report discusses a diagnosis of intravitreal glioma in a boy aged 7 years with neurofibromatosis type 1. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 18, 2023 Category: Opthalmology Source Type: research
Subretinal Deposits Associated With Type 1 Cryoglobulinemia
This case report describes a female patient aged 30 years who presented with subretinal deposits and blurry vision in the setting of type 1 cryoglobulinemia. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 18, 2023 Category: Opthalmology Source Type: research
Pulsed Oral Azithromycin vs 6-Week Oral Doxycycline for Moderate to Severe Meibomian Gland Dysfunction
This randomized clinical trial attempts to determine if the adverse effects of a 3-week course of oral azithromycin were equivalent to the adverse effects of a 6-week course of oral doxycycline. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Evaluating the Evidence for Treatment of Meibomian Gland Dysfunction With Oral Antibiotics
In this issue of JAMA Ophthalmology, Upaphong et al report the results of a high-quality equivalence clinical trial comparing the efficacy of a 3-week course of weekly oral azithromycin with that of a 6-week course of oral doxycycline for treatment of moderate to severe meibomian gland dysfunction (MGD), showing that the 2 treatments are equivalent with respect to total MGD score and ocular surface disease index at both 6 and 8 weeks of follow-up. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
JAMA Ophthalmology —The Year in Review, 2022
The processes and policies for peer review of publications in the medical literature continue to evolve for the better each year, and for readers, authors, and editors of JAMA Ophthalmology, 2022 is no exception. Three such changes that may have profound effects on ophthalmology practice and reporting are discussed below. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Multidrug-Resistant Pseudomonas aeruginosa Keratitis Associated With Artificial Tear Use
This case report describes severe multidrug-resistant Pseudomonas aeruginosa keratitis in a 72-year-old man after EzriCare artificial tear use. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Potential Rare Danger of Presumably Benign Artificial Tears
Of all the medications we prescribe and procedures we perform as ophthalmologists, artificial tears are generally considered the most benign. The effectiveness of artificial tears is often debated, but until recently, few ophthalmologists had concerns regarding their safety. However, the current outbreak of Verona Integron-mediated Metallo- ß-lactamase (VIM) and Guiana-Extended Spectrum-ß-Lactamase (GES)-producing carbapenem-resistant (VIM-GES-CRPA), a rare strain of extensively drug-resistant Pseudomonas aeruginosa, associated with the use of carboxymethylcellulose sodium (EzriCare) multidose preservative-free artificia...
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Pseudomonas aeruginosa Corneal Ulcer Associated With Artificial Tears Eye Drops
This case report describes vision loss in a 72-year-old woman following use of EzriCare eye drops. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Intimate Partner Violence-Related Ocular Trauma in the US
This cross-sectional study investigates the epidemiological pattern of intimate partner violence –related ocular injury in adults in the US. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Intimate Partner Violence and the Role of Ophthalmology
Around the globe, billions of people ’s lives continue to be affected by violence every year, with significant associated morbidity and mortality. One in 3 female individuals, 16 years or older, is reported to have been subjected to physical or sexual violence, usually by an intimate partner. A review of 48 population-based studies i n 2017 identified that 45% injuries from intimate partner violence (IPV) involve the eyes. In this issue of JAMA Ophthalmology, Alik et al ask the question, “What is the epidemiological pattern of IPV-related ocular injury in the adult population of the US?” Their analysis identifies imp...
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
Association Between Social Determinants of Health and Examination-Based Vision Loss vs Self-reported Vision Measures
This study attempts to identify associations between social determinants of health and evaluated vision impairment and assesses whether these associations hold when examining self-reported vision loss. (Source: JAMA Ophthalmology)
Source: JAMA Ophthalmology - May 1, 2023 Category: Opthalmology Source Type: research
